Integrated genomic view of SARS-CoV-2 in India
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
India first detected SARS-CoV-2, causal agent of COVID-19 in late January-2020, imported from Wuhan, China. March-2020 onwards; importation of cases from rest of the countries followed by seeding of local transmission triggered further outbreaks in India. We used ARTIC protocol based tiling amplicon sequencing of SARS-CoV-2 (n=104) from different states of India using a combination of MinION and MinIT from Oxford Nanopore Technology to understand introduction and local transmission. The analyses revealed multiple introductions of SARS-CoV-2 from Europe and Asia following local transmission. The most prevalent genomes with patterns of variance (confined in a cluster) remain unclassified, here, proposed as A4-clade based on its divergence within A-cluster. The viral haplotypes may link their persistence to geo-climatic conditions and host response. Despite the effectiveness of non-therapeutic interventions in India, multipronged strategies including molecular surveillance based on real-time viral genomic data is of paramount importance for a timely management of the pandemic.
Article activity feed
-
SciScore for 10.1101/2020.06.04.128751: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Samples from each group were selected and further processed for WGS of the SARS-CoV-2. WGSsuggested: NoneIllumina’s MiSeq platform was used for sequencing. MiSeqsuggested: (A5-miseq, RRID:SCR_012148)Phylogeny and network analysis: The fasta sequences were aligned using MAFFT considering the MN90894.3 version as the reference sequence. MAFFTsuggested: (MAFFT, RRID:SCR_011811)FIGTREE was used for the graphical visualisation of Phylogenetic analysis … SciScore for 10.1101/2020.06.04.128751: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Samples from each group were selected and further processed for WGS of the SARS-CoV-2. WGSsuggested: NoneIllumina’s MiSeq platform was used for sequencing. MiSeqsuggested: (A5-miseq, RRID:SCR_012148)Phylogeny and network analysis: The fasta sequences were aligned using MAFFT considering the MN90894.3 version as the reference sequence. MAFFTsuggested: (MAFFT, RRID:SCR_011811)FIGTREE was used for the graphical visualisation of Phylogenetic analysis (http://tree.bio.ed.ac.uk/software/figtree). FIGTREEsuggested: (FigTree, RRID:SCR_008515)Pheatmap and complex heatmap packages from R were used to plot the heatmaps. Pheatmapsuggested: (pheatmap, RRID:SCR_016418)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 23. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
